Mumbai-based Shreya Life Sciences, known for pharmaceuticals, is reportedly exporting Nvidia AI chips to Russia despite Western sanctions. Trade records reveal Shreya’s role in rerouting Dell servers with Nvidia processors, spotlighting India’s intermediary role in Russia’s high-tech imports amid tightening restrictions.
Inside Shreya Life Sciences — the Indian drugmaker accused of supplying Russia with Nvidia AI chips
This was originally published on post